Author Correction: Hyperpolarised ¹³C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer

Affiliations

• ¹ Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
• ² Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
• ³ Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
• ⁴ Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
• ⁵ School of Allied Health, Anglia Ruskin University, Cambridge, UK.
• ⁶ Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
• ⁷ Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
• ⁸ Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
• ⁹ Department of Clinical Science, University of Bergen, Bergen, Norway.
• ¹⁰ GE Healthcare, Aurora, OH, USA.
• ¹¹ GE Healthcare, Munich, Germany.
• ¹² Division of Urology, Department of Surgery, University of Cambridge, Cambridge, UK.
• ¹³ Cambridge Urology Translational Research and Clinical Trials Office, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, UK.
• ¹⁴ Department of Biochemistry, University of Cambridge, Cambridge, UK.
• ¹⁵ Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK. tb507@medschl.cam.ac.uk.